74 reports

  • Colorectal cancer
  • Market segmentation by application

About GI stool testing Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption...

  • Colorectal Cancer
  • Infectious Disease
  • World
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Global colonoscopy devices market segmentation by geography: Growth lifecycle analysis
  • COLONOSCOPY DEVICES MARKET IN AMERICAS

You can easily book an appointment with one online.

  • Colorectal Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation
  • ENDOSCOPY: KEY METRICS IN THE 10MM, 2014-2021

GASTROINTESTINAL ENDOSCOPY; ##: ##-##.

  • Colorectal Cancer
  • Market Size
  • Arthrex, Inc.
  • Boston Scientific Corporation
  • EndoChoice, Inc.

GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW ## COMPETITIVE ANALYSIS ## MARKET TRENDS ## MARKET DEVELOPMENTS ## PROCEDURE NUMBERS ## PROCEDURE CODES INVESTIGATED ## MARKETS INCLUDED ## ##. ## KEY REPORT UPDATES ## VERSION HISTORY ## RESEARCH METHODOLOGY ## ##. ## RESEARCH SCOPE ## ##. ## I

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Introduction
  • 2.4.3 BIOMARKERS/TARGETS OF INTEREST

Grade ## hypertension (##% vs ##%), proteinuria (##% vs ##%), arterial thromboembolic events (##% vs ##%), and gastrointestinal perforation (##% vs ##%) were more commonly observed in the bevacizumab plus mIFL group than in the mIFL group.

  • Cancer
  • Colorectal Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • CLINICAL AND COMMERCIAL POSITIONING OF FAMITINIB
  • 4.1 DISEASE BACKGROUND

JOURNAL OF GASTROINTESTINAL ONCOLOGY, ##(##):##-##.

  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • CS-2164 - DRUG PROFILE
  • CS-2164 - DRUG PROFILE

Hoffmann-La Roche Ltd Ascentage Pharma Group Corp Ltd Blueprint Medicines Corp Indication Name Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Stromal Tumor (GIST)

  • Colorectal Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • Identifying factors impacting market growth
  • Market size and forecast 2017-2022

You can easily book an appointment with one online.

  • Colorectal Cancer
  • Forecast
  • Market Size
  • Danaher Corporation
  • Epigenomics AG
  • 2.1 DISEASE BACKGROUND

World Journal of Gastrointestinal Oncology; ##(##): ##-##.

  • Colorectal Cancer
  • China
  • United States
  • Forecast
  • Cancer Epidemiology Group

Gastrointestinal Cancers Symposium for Taiho Oncology’s Lonsurf (trifluridine and tipiracil); views on new data announced from the Phase II CheckMate-## trial evaluating Opdivo (nivolumab; Merck & Co. ) and Yervoy (ipilimumab; BMS) for the treatment of patients with DNA mismatch repair

  • Cancer Immunotherapy
  • Colorectal Cancer
  • Monoclonal Antibody
  • Oncology
  • Therapy
  • DISEASE OVERVIEW
  • Key events impacting the CRC marketplace are categorized into three subtypes.*

MOST CASES OF CRC PRESENT AS ADENOCARCINOMAS, BUT OTHER TYPES OF CRC INCLUDE GASTROINTESTINAL CARCINOID TUMORS, GASTROINTESTINAL STROMAL TUMORS, PRIMARY COLORECTAL LYMPHOMA, LEIOMYOSARCOMA, MELANOMA, AND SQUAMOUS CELL CARCINOMA.

  • Colorectal Cancer
  • China
  • United States
  • Array BioPharma Inc.
  • Eli Lilly & Co.
  • 15. Market Challenges
  • 13. Market Growth Drivers

The magnitude of the impact has been categorized as described below: Low Moderate - Medium-level impact on the market High - Negligible or no impact on the market landscape - Very high impact, with radical influence on the growth of the market ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • 5.2 References
  • Introduction

Gastrointestinal Cancer Research; ##(##); ##-## Mao Y, et al. (2003).

  • Cancer
  • Colorectal Cancer
  • Therapy
  • United States
  • Roche Group

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

Colorectal cancer

4546 5000 3864
  • MASITINIB DRUG PROFILE
  • PERCENTAGE OF STAGE IV RECTAL CANCER PATIENTS RECEIVING EACH TREATMENT TYPE

Gastrointestinal Cancer: Targets and Therapy, ##(##), ##-##.

  • Colorectal Cancer
  • European Union
  • Japan
  • North America
  • United States

PLoS ONE. 2016; ##(##):##- ##. ##.

  • Colorectal Cancer
  • Italy
  • North America
  • South America
  • Southern Europe
  • Medical Care 12%
  • It focuses on success of company by developing novel products in Asia/Pacific region

CPX-## by Celator Pharmaceuticals is a liposomal formulation of a synergistic ##:## molar ratio of floxuridine and irinotecan HCI.

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

The panel reported includes two proprietary assays and one non-proprietary assay.

  • Colorectal Cancer
  • Medical Device
  • Medical Equipment
  • United States
  • VolitionRx Limited

ONE UNIT REFERS TO ONE FLEXIBLE VIDEO COLONOSCOPE.

  • Clinical Trial
  • Colorectal Cancer
  • Endoscope
  • United States
  • Smart Medical Systems, Ltd.
  • JAN 21, 2016: XBIOTECH TO ATTEND AND PRESENT AT THE ASCO 2016 GASTROINTESTINAL CANCERS SYMPOSIUM
  • MAY 24, 2016: XBIOTECH TO PRESENT POSITIVE PRELIMINARY SURVIVAL DATA ON XILONIX(TM) AT THE 18TH EUROPEAN SOCIETY OF MEDICAL ONCOLOGY WORLD CONGRESS ON GASTROINTESTINAL CANCER

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) targeted pipeline...

  • Colorectal Cancer
  • Therapy
  • Europe
  • European Union
  • XBiotech Inc.
  • JAN 21, 2016: XBIOTECH TO ATTEND AND PRESENT AT THE ASCO 2016 GASTROINTESTINAL CANCERS SYMPOSIUM
  • MAY 24, 2016: XBIOTECH TO PRESENT POSITIVE PRELIMINARY SURVIVAL DATA ON XILONIX(TM) AT THE 18TH EUROPEAN SOCIETY OF MEDICAL ONCOLOGY WORLD CONGRESS ON GASTROINTESTINAL CANCER

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) targeted pipeline therapeutics....

  • Colorectal Cancer
  • Therapy
  • United States
  • Product Initiative
  • XBiotech Inc.
  • RESMINOSTAT - DRUG PROFILE

Median follow-up was ## ## months (IQR ## ##-## ##).

  • Cancer
  • Colorectal Cancer
  • United States
  • Company Operations
  • Product Initiative

This work was supported by a Rutgers Cancer Institute of New Jersey Gastrointestinal Oncology Pilot Grant to Drs.

  • Colorectal Cancer
  • Therapy
  • World
  • Product Initiative
  • Etubics Corporation
  • FEB 06, 2018: ARRAY BIOPHARMA REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER OF FISCAL 2018

The data were presented at the ASCO 2018 Gastrointestinal Cancers Symposium in San Francisco, California.

  • Biopharmaceutical
  • Colorectal Cancer
  • Pharmaceutical
  • United States
  • BioPharma company

Gastrointestinal events were predominantly grade ##/ ##, early in onset, and usually subsided within a month. ## DAS-I pts had grade ## pleural effusions; both had these events on prior DAS and were grade ## on study entry.

  • Colorectal Cancer
  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • be driven by its ability to impact hypoxic and highly-vascularized tumors.
  • in colorectal cancer (CRC) models."

One patient had a Sprycel-related AE leading to discontinuation, and one patient died from gastrointestinal bleeding unrelated to treatment.

  • Breast Cancer
  • Colorectal Cancer
  • Targeted Therapy
  • Therapy
  • Pfizer Inc.
  • BREAST CANCER
  • TIVANTINIB - DRUG PROFILE

The data were presented at the 2016 Gastrointestinal Cancers Symposium (ASCO GI).

  • Breast Cancer
  • Colorectal Cancer
  • Monoclonal Antibody
  • Therapy
  • Daiichi Sankyo Company

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company